Study Stopped
Early interruption caused by the COVID-19 pandemic.
Hemodynamic and Salivary Responses of 12 Weeks of Training With Different Anti-hypertensive
Hemodynamic Responses and Salivary Markers of the Interaction of 12 Weeks of Training With Different Anti-hypertensive in Menopausal Women
1 other identifier
interventional
30
1 country
1
Brief Summary
Different classes of antihypertensives may have different responses when associated with exercise. Thus, this study aims to compare the responses of the association of 12 weeks of aerobic exercise and weightlifting with different classes of medications in 45 postmenopausal hypertensive women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Mar 2017
Longer than P75 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2017
CompletedFirst Submitted
Initial submission to the registry
May 8, 2018
CompletedFirst Posted
Study publicly available on registry
May 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedMarch 22, 2022
March 1, 2022
2 years
May 8, 2018
March 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Ambulatorial Blood Pressure
All volunteers were submitted to a 24-hour Blood Pressure (BP; systolic and diastolic measurements) assessment by Ambulatorial Blood Pressure Monitoring (ABPM) before and after 10 weeks of combined exercise training, with a minimum of 48 hours after the last training session. A device was used associated with a diary of examination to self-report of activities of daily living (sleep, work, food) or any event that could interfere abnormally with BP or device measurements. The device was always placed 7am and the measurements were made every 15 minutes from 7h to 23h and every 30 minutes from 23h to 7h. The monitoring was considered valid when it happened for a period of 24 hours. The following results were evaluated: systolic blood pressure; diastolic blood pressure, mean blood pressure and heart rate in awake, sleep and 24-hour periods. Before the use ABPM during daily activities, resting blood pressure were measured using the same equipment after 15 min of rest in siting position.
Before and within 72 hours after 12 weeks of exercise training
Secondary Outcomes (5)
Changes in Ambulatorial Blood Pressure Variability
Before and within 72 hours after 12 weeks of exercise training
Changes in Heart Rate Variability
Before and within 72 hours after 12 weeks of exercise training
Changes in salivary oxidative stress
Before and within 72 hours after 12 weeks of exercise training
Changes of blood pressure reactivity
Before and within 72 hours after 12 weeks of exercise training
Changes of Biochemical markers on blood
Before and within 72 hours after 12 weeks of exercise training
Study Arms (3)
No medication
PLACEBO COMPARATORGroup of pre-hypertensive women with no medication who practiced 12 weeks of training with Combined Exercise Training, non-obese, nonsmokers and with no characteristics that prevented them from performing the activities. In addition this group could not modify the dose or type of the medicine and should be using the same medicine and dose for at least 6 months
Angiotensin receptor blockers
ACTIVE COMPARATORGroup of hypertensive women taking Angiotensin receptor blockers who practiced 12 weeks of training with Combined Exercise Training, non-obese, nonsmokers and with no characteristics that prevented them from performing the activities. In addition this group could not modify the dose or type of the medicine and should be using the same medicine and dose for at least 6 months
Beta blockers
ACTIVE COMPARATORGroup of hypertensive women taking Beta blockers who practiced 12 weeks of training with Combined Exercise Training, non-obese, nonsmokers and with no characteristics that prevented them from performing the activities. In addition this group could not modify the dose or type of the medicine and should be using the same medicine and dose for at least 6 months
Interventions
The program consisted of 36 sessions of combined aerobic and resistance exercises training during 12 consecutive weeks. Each session lasted 60 minutes and consisted of 30 minutes of resistance exercise and 30 minutes of aerobic exercise. The resistance training was performed in two sets of 8 to 12 repetitions in five exercises of weight training (Based on 1 repetition maximum test - 1RM). The aerobic exercise was performed on a treadmill, at a speed of 5.5 km/h and intensity (imposed by treadmill inclination and heart rate) between 65 and 75% of maximun heart rate measured in maximum incremental test. Every week the resistance load and aerobic intensity was readjusted by determined training zone (8 to 12 maximum repetitions) and heart rate predicted in the incremental respectively.
Eligibility Criteria
You may qualify if:
- Women aged between 50 and 70 years;
- Be in the postmenopausal phase;
- Be able to practice physical exercise on treadmill and bodybuilding,
- Receive a release certificate for exercise practice;
- Do not present physical problems or cardiovascular complications that prevent the performance of physical exercises;
- In the case of hypertensives: present stage 1 hypertension, according to the guidelines of the Brazilian Society of Hypertension (2010);
- In the case of hypertensive patients, undergo drug treatment with β-blockers or Angiotensin receptor blockers.
You may not qualify if:
- Present history of stroke or acute myocardial infarction;
- Smokers;
- Present diagnosis of Diabetes Mellitus or renal pathologies;
- Use of antihypertensive drugs from classes that were not selected for this project;
- Make use of hormonal therapies;
- Being uncompensated hypertensive.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guilherme Morais Puga
Uberlândia, Minas Gerais, 38400-678, Brazil
Related Publications (1)
Mariano IM, Amaral AL, V Carrijo VH, Costa JG, Rodrigues ML, Cunha TM, Puga GM. Different cardiovascular responses to exercise training in hypertensive women receiving beta-blockers or angiotensin receptor blockers: A pilot study. Clin Exp Hypertens. 2022 Jul 4;44(5):442-450. doi: 10.1080/10641963.2022.2065290. Epub 2022 Apr 23.
PMID: 35465803DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Bachelor
Study Record Dates
First Submitted
May 8, 2018
First Posted
May 18, 2018
Study Start
March 1, 2017
Primary Completion
March 1, 2019
Study Completion
March 1, 2021
Last Updated
March 22, 2022
Record last verified: 2022-03